3 years ago
ARWR
AnalystsEdward TenthoffEdward Tenthoff's Stock Forecasts
AnalystsEdward Tenthoff
Sectors:
Analyst Ranking
Bottom 1%
#5108 out of 5150 analysts
Average Return
-8.17%
Win Rate
37%71 out of 194
Risk vs Reward
Poor
Good
Edward Tenthoff's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Omega Therapeutics IncOMGAQ | +267.18% | $2.62 | $9.62 | 2022-05-23 - 2023-05-22 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +249.48% | $3.84 | $13.42 | 2017-11-27 - 2018-11-27 | Strong Buy |
Poseida Therapeutics IncPSTX | +231.58% | $2.85 | $9.45 | 2023-12-11 - 2024-12-10 | Strong Buy |
Kymera Therapeutics IncKYMR | +225.65% | $14.27 | $46.47 | 2023-11-03 - 2024-11-01 | Strong Buy |
Moderna IncMRNA | +187.99% | $143.66 | $413.72 | 2021-03-15 - 2021-08-06 | Strong Buy |
Edward Tenthoff Analyst Color
Get additional color on Edward Tenthoff's coverage of popular stocks
3 years ago
FULC
3 years ago
STRO
3 years ago
MRNA
3 years ago
ALNY
3 years ago
RAPT
3 years ago
ASLN
3 years ago
MCRB
3 years ago
ATYR
3 years ago
PSTX
3 years ago
CRSP
4 years ago
ALNY
4 years ago
ARGX
4 years ago
MRNA
Edward Tenthoff's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $45.00 | +72.94% | Reiterates | 3 days ago |
Kymera Therapeutics IncKYMR | 5 | Strong Buy | $125.00 | +39.38% | Reiterates | 4 days ago |
Fulcrum Therapeutics IncFULC | 6 | Strong Buy | $23.00 | +76.92% | Reiterates | 5 days ago |
Moderna IncMRNA | 12 | Strong Buy | $63.00 | +113.85% | Reiterates | 22 days ago |
Arrowhead Pharmaceuticals IncARWR | 9 | Strong Buy | $70.00 | -0.13% | Maintains | 24 days ago |
Inovio Pharmaceuticals IncINO | 2 | Strong Buy | $6.00 | +191.26% | Reiterates | a month ago |
Alnylam Pharmaceuticals IncALNY | 7 | Strong Buy | $489.00 | +23.00% | Reiterates | a month ago |
Karyopharm Therapeutics IncKPTI | 1 | Strong Buy | $12.00 | +72.66% | Reiterates | 2 months ago |
Camp4 Therapeutics CorpCAMP | 2 | Strong Buy | $12.00 | +84.90% | Maintains | 3 months ago |
Nextcure IncNXTC | 5 | Strong Buy | $15.00 | +34.65% | Maintains | 5 months ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $105.00 | +85.25% | Reiterates | 6 months ago |
Sutro Biopharma IncSTRO | 7 | Strong Buy | $20.00 | +103.46% | Upgrades | 6 months ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $7.00 | +396.45% | Assumes | 6 months ago |
Iteos Therapeutics IncITOS | 1 | Strong Buy | $12.00 | +18.23% | Maintains | 7 months ago |
Arvinas IncARVN | 6 | Strong Buy | $14.00 | +11.29% | Reiterates | 7 months ago |
Century Therapeutics IncIPSC | 8 | Strong Buy | $2.00 | +258.42% | Maintains | 9 months ago |
Dyne Therapeutics IncDYN | 5 | Strong Buy | $48.00 | +149.09% | Maintains | 9 months ago |
Mesoblast LtdMESO | 5 | Strong Buy | $24.00 | +32.82% | Reiterates | 10 months ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $78.00 | +249.46% | Reiterates | a year ago |
Xencor IncXNCR | 3 | Strong Buy | $30.00 | N/A | Upgrades | a year ago |
Omega Therapeutics IncOMGAQ | 5 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 6 | Hold | $1.00 | N/A | Downgrades | a year ago |
Tempest Therapeutics IncTPST | 4 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Skye Bioscience IncSKYE | 3 | Strong Buy | $20.00 | N/A | Reiterates | a year ago |
Opko Health IncOPK | 5 | Strong Buy | $3.00 | N/A | Reiterates | a year ago |
Syros Pharmaceuticals IncSYRS | 5 | Strong Buy | $5.00 | N/A | Reiterates | a year ago |
Cue Biopharma IncCUE | 4 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Monte Rosa Therapeutics IncGLUE | 3 | Strong Buy | $16.00 | N/A | Reiterates | a year ago |
Fate Therapeutics IncFATE | 5 | Strong Buy | $6.00 | N/A | Upgrades | a year ago |
Aptose Biosciences IncAPTOF | 4 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Aslan Pharmaceuticals LtdASLN | 5 | Strong Buy | $80.00 | N/A | Reiterates | 2 years ago |
Milestone Pharmaceuticals IncMIST | 3 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Poseida Therapeutics IncPSTX | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Gamida Cell LtdGMDAQ | 2 | Strong Buy | $2.00 | N/A | Maintains | 2 years ago |
Point Biopharma Global IncPNT | 2 | Hold | $12.50 | N/A | Downgrades | 2 years ago |
Gritstone Bio IncGRTSQ | 2 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Rapt Therapeutics IncRAPT | 5 | Strong Buy | $248.00 | N/A | Maintains | 2 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Atyr Pharma IncATYR | 6 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Jounce Therapeutics IncJNCE | 3 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 3 years ago |
Aravive IncARAV | 1 | Strong Buy | $2.00 | N/A | Maintains | 3 years ago |
Seres Therapeutics IncMCRB | 3 | Strong Buy | $180.00 | N/A | Maintains | 3 years ago |
Puretech Health PLCPRTC | 1 | Strong Buy | $44.00 | N/A | Maintains | 3 years ago |
Infinity Pharmaceuticals IncINFI | 3 | Strong Buy | $3.00 | N/A | Maintains | 4 years ago |
Eloxx Pharmaceuticals IncELOX | 2 | Strong Buy | $60.00 | N/A | Maintains | 4 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $37.00 | N/A | Maintains | 4 years ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $100.00 | N/A | Maintains | 4 years ago |
Aptevo Therapeutics IncAPVO | 3 | Strong Buy | $651,200.00 | N/A | Maintains | 4 years ago |
Argenx SeARGX | 3 | Strong Buy | $354.00 | N/A | Upgrades | 4 years ago |
Synlogic IncSYBX | 2 | Strong Buy | $135.00 | N/A | Maintains | 4 years ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $323.00 | N/A | Maintains | 4 years ago |
Chemocentryx IncCCXI | 1 | Hold | $25.00 | N/A | Downgrades | 5 years ago |
Exelixis IncEXEL | 1 | Strong Buy | $36.00 | N/A | Maintains | 5 years ago |
Kaleido Biosciences IncKLDO | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 5 years ago |
Catheter Precision IncVTAK | 3 | Hold | $25.00 | N/A | Maintains | 6 years ago |
Marker Therapeutics IncMRKR | 2 | Hold | $25.00 | N/A | Downgrades | 6 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Strong Buy | $18.50 | N/A | Reiterates | 6 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 6 years ago |
Igm Biosciences IncIGMS | 1 | Strong Buy | $53.00 | N/A | Maintains | 6 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $75.00 | N/A | Upgrades | 7 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 8 years ago |
Oncomed Pharmaceuticals IncOMED | 1 | Hold | $5.00 | N/A | Downgrades | 9 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.